316 related articles for article (PubMed ID: 30053207)
1. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
2. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
[TBL] [Abstract][Full Text] [Related]
3. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
4. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
5. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
Shelley Hwang E; Thompson A
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376162
[No Abstract] [Full Text] [Related]
6. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
7. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Rakovitch E; Gray R; Baehner FL; Sutradhar R; Crager M; Gu S; Nofech-Mozes S; Badve SS; Hanna W; Hughes LL; Wood WC; Davidson NE; Paszat L; Shak S; Sparano JA; Solin LJ
Breast Cancer Res Treat; 2018 Jun; 169(2):359-369. PubMed ID: 29388015
[TBL] [Abstract][Full Text] [Related]
8. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
9. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
[TBL] [Abstract][Full Text] [Related]
10. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
12. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
[TBL] [Abstract][Full Text] [Related]
13. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
14. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
15. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Sagara Y; Freedman RA; Vaz-Luis I; Mallory MA; Wong SM; Aydogan F; DeSantis S; Barry WT; Golshan M
J Clin Oncol; 2016 Apr; 34(11):1190-6. PubMed ID: 26834064
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.
Warren LEG; Chen YH; Halasz LM; Brock JE; Capuco A; Punglia RS; Wong JS; Golshan M; Bellon JR
Breast Cancer Res Treat; 2019 Dec; 178(3):607-615. PubMed ID: 31493031
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
20. The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.
Polgár C; Kahán Z; Orosz Z; Gábor G; Hadijev J; Cserni G; Kulka J; Jani N; Sulyok Z; Lázár G; Boross G; Diczházi C; Szabó E; László Z; Péntek Z; Major T; Fodor J
Pathol Oncol Res; 2008 Jun; 14(2):179-92. PubMed ID: 18438723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
